Trial Outcomes & Findings for A Trial of Mechanical Axis vs Kinematic Alignment in Total Knee Replacement (NCT NCT02527148)
NCT ID: NCT02527148
Last Updated: 2025-05-15
Results Overview
To demonstrate, through calculation of Oxford Knee Score (OKS) post operatively, that total knee replacement (TKR) performed using the ShapeMatch® Cutting Guide provides improvement from preoperative levels of patient pain and function comparable to the improvement obtained with TKR performed using computer-assisted Navigation. Oxford Knee Scores will be calculated pre-operatively and at 6 weeks, 6 months, 12 months, 2 years and 5 years. The OKS is a participant completed 12 question form on activities of daily living that assess function and pain. Scores can range from 0 to 48 with lower scores indicating a poor outcome and higher scores indicating a more satisfactory joint outcome.
COMPLETED
NA
100 participants
Preoperatively, 6-week, 6-months, 12 months, 2 years and 5 years postoperatively
2025-05-15
Participant Flow
For all results participants=knees.
Participant milestones
| Measure |
OtisMed® ShapeMatch® With Triathlon
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Overall Study
STARTED
|
50
|
50
|
|
Overall Study
COMPLETED
|
49
|
50
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
| Measure |
OtisMed® ShapeMatch® With Triathlon
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Overall Study
Did not receive study intervention
|
1
|
0
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
Total
n=99 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
71.9 years
STANDARD_DEVIATION 6.5 • n=49 Participants
|
69.6 years
STANDARD_DEVIATION 7.5 • n=50 Participants
|
70.8 years
STANDARD_DEVIATION 7.0 • n=99 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=49 Participants
|
26 Participants
n=50 Participants
|
51 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
24 Participants
n=49 Participants
|
24 Participants
n=50 Participants
|
48 Participants
n=99 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
New Zealand
|
49 participants
n=49 Participants
|
50 participants
n=50 Participants
|
99 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Preoperatively, 6-week, 6-months, 12 months, 2 years and 5 years postoperativelyPopulation: Shapematch: 49 had preoperative,48 had 6 week, 46 had 6 months, 48 had 12 month, 49 had 2 year and 47 had 5 year scores. Navigation: 50 had preoperative, 47 had 6 week, 46 had 6 months, 49 had 12 month, 50 had 2 years and 48 had 5 years scores. Participants=knees
To demonstrate, through calculation of Oxford Knee Score (OKS) post operatively, that total knee replacement (TKR) performed using the ShapeMatch® Cutting Guide provides improvement from preoperative levels of patient pain and function comparable to the improvement obtained with TKR performed using computer-assisted Navigation. Oxford Knee Scores will be calculated pre-operatively and at 6 weeks, 6 months, 12 months, 2 years and 5 years. The OKS is a participant completed 12 question form on activities of daily living that assess function and pain. Scores can range from 0 to 48 with lower scores indicating a poor outcome and higher scores indicating a more satisfactory joint outcome.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Oxford Knee Score
Oxford preoperative
|
20.3 units on a scale
Standard Deviation 5.7
|
21.1 units on a scale
Standard Deviation 6.2
|
|
Oxford Knee Score
Oxford 6 weeks
|
32.5 units on a scale
Standard Deviation 6.8
|
32.8 units on a scale
Standard Deviation 7.7
|
|
Oxford Knee Score
Oxford 6 months
|
41.0 units on a scale
Standard Deviation 4.8
|
38.2 units on a scale
Standard Deviation 7.3
|
|
Oxford Knee Score
Oxford 12 months
|
41.8 units on a scale
Standard Deviation 6.1
|
43.0 units on a scale
Standard Deviation 7.7
|
|
Oxford Knee Score
Oxford 2 years
|
42.1 units on a scale
Standard Deviation 6.1
|
41.1 units on a scale
Standard Deviation 6.0
|
|
Oxford Knee Score
Oxford 5 years
|
41.4 units on a scale
Standard Deviation 7.2
|
41.7 units on a scale
Standard Deviation 6.3
|
SECONDARY outcome
Timeframe: Intraoperative - participants were followed for the duration of the operation, an average of 1 hour and 50 minutes.Skin to skin time is the time in minutes from initial skin incision to skin closure. Anaesthesia time is the time in minutes that anaesthesia administration is started to the time it is stopped. Data for anaesthesia time is not available due to an error on the original case report form that did not correctly capture anaesthesia time.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Cost Effectiveness: Total Duration of Operating Procedure (Anaesthetic Time and Skin-to-skin Incision Time)
|
82.6 minutes
Standard Deviation 26
|
92.2 minutes
Standard Deviation 32
|
SECONDARY outcome
Timeframe: Intraoperative - participants were followed for the duration of the operation, an average of 1 hour and 50 minutes.To compare the cost-effectiveness and cost-utility of the procedure between the ShapeMatch® Cutting Guide group and the computer-assisted Navigation control group the surgical incision length is reported in mm.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Cost Effectiveness: Wound Length
|
223 millimeters
Standard Deviation 29
|
233 millimeters
Standard Deviation 34
|
SECONDARY outcome
Timeframe: Intraoperative - participants were followed for the duration of the operation, an average of 1 hour and 50 minutes.Population: Cost effectiveness data is not available.
To compare the cost-effectiveness and cost-utility of the procedure between the ShapeMatch® Cutting Guide group and the computer-assisted Navigation control group. The data for the cost of consumable items used during the operating procedure is not available. Due to limited site resources, a decision was made not to collect this secondary outcome measure data.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 14 daysTo compare the cost-effectiveness and cost-utility of the procedure between the ShapeMatch® Cutting Guide group and the computer-assisted Navigation control group the length of stay in number of days spent in the hospital is reported..
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Cost Effectiveness: Length of Stay in Hospital
|
5.1 days
Standard Deviation 3.0
|
4.2 days
Standard Deviation 4.2
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: Shapematch preoperative N=48, 12 month N=48. Navigation preoperative N=50, 12 month N-49.
A quality-adjusted life-year (QALY) takes into account both the quantity and quality of life generated by healthcare interventions. It is the arithmetic product of life expectancy and a measure of the quality of the remaining life-years. A QALY places a weight on time in different health states. A year of perfect health is worth 1 and a year of less than perfect health is worth less than 1. Death is considered to be equivalent to 0; however,some health states may be considered worse than death and have negative scores.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=48 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Cost Effectiveness: Quality-adjusted Life-years (QALYs) From EQ-5D-3L
Preoperative QALY
|
0.507 QALY life year
Standard Deviation 0.17
|
0.484 QALY life year
Standard Deviation 0.21
|
|
Cost Effectiveness: Quality-adjusted Life-years (QALYs) From EQ-5D-3L
12 Month QALY
|
0.895 QALY life year
Standard Deviation 0.16
|
0.852 QALY life year
Standard Deviation 0.19
|
SECONDARY outcome
Timeframe: Preoperatively, 6-week, 6-months,12 months, 2 years and 5 years postoperativelyPopulation: Patients did not complete CRF to protocol in some instances, resulting in exclusion/missing data points.
Pain at rest and pain during mobilization was measured using a 10 centimeter Visual Analogue Scale (VAS). Participants are asked to indicate their level of pain with 0 being no pain and 10 being the worst pain.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Knee Pain
Pre-op Pain at Rest
|
4.36 score on a scale
Standard Deviation 2.03
|
4.20 score on a scale
Standard Deviation 2.48
|
|
Knee Pain
Pre-op Pain at Mobilisation
|
5.78 score on a scale
Standard Deviation 2.32
|
6.01 score on a scale
Standard Deviation 2.49
|
|
Knee Pain
6-week Pain at Rest
|
1.95 score on a scale
Standard Deviation 1.93
|
1.79 score on a scale
Standard Deviation 2.01
|
|
Knee Pain
6-week Pain at Mobilisation
|
2.51 score on a scale
Standard Deviation 2.11
|
2.49 score on a scale
Standard Deviation 2.00
|
|
Knee Pain
6-month Pain at Rest
|
0.97 score on a scale
Standard Deviation 1.78
|
1.20 score on a scale
Standard Deviation 2.04
|
|
Knee Pain
6-month Pain at Mobilisation
|
1.15 score on a scale
Standard Deviation 1.97
|
1.50 score on a scale
Standard Deviation 2.38
|
|
Knee Pain
1-year Pain at Rest
|
0.53 score on a scale
Standard Deviation 1.35
|
0.84 score on a scale
Standard Deviation 1.63
|
|
Knee Pain
1-year Pain at Mobilisation
|
0.79 score on a scale
Standard Deviation 1.83
|
1.35 score on a scale
Standard Deviation 2.3
|
|
Knee Pain
2-year Pain at Rest
|
0.67 score on a scale
Standard Deviation 0.94
|
1.00 score on a scale
Standard Deviation 1.72
|
|
Knee Pain
2-year Pain at Mobilisation
|
1.14 score on a scale
Standard Deviation 1.35
|
1.31 score on a scale
Standard Deviation 1.84
|
|
Knee Pain
5-year Pain at Rest
|
0.84 score on a scale
Standard Deviation 1.56
|
0.63 score on a scale
Standard Deviation 1.07
|
|
Knee Pain
5-year Pain at Mobilisation
|
1.21 score on a scale
Standard Deviation 1.64
|
1.17 score on a scale
Standard Deviation 2.06
|
SECONDARY outcome
Timeframe: Preoperatively, 6-week, 6-months,12 months, 2 years and 5 years postoperativelyPopulation: Patients did not complete CRF to protocol in some instances, resulting in exclusion/missing data points.
The WOMAC is completed by the participant and measures five items for pain (score range 0-100), two for stiffness (score range 0-100), and 17 for functional limitation (score range 0-100). The total score is the sum of these three categories.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Pre-op
|
50.05 score on a scale
Standard Deviation 13.07
|
50.36 score on a scale
Standard Deviation 14.91
|
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
6-week
|
74.74 score on a scale
Standard Deviation 11.75
|
73.06 score on a scale
Standard Deviation 17.61
|
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
6-month
|
87.89 score on a scale
Standard Deviation 9.73
|
81.79 score on a scale
Standard Deviation 15.94
|
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
1-year
|
90.86 score on a scale
Standard Deviation 11.14
|
86.79 score on a scale
Standard Deviation 14.93
|
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
2-year
|
88.36 score on a scale
Standard Deviation 13.60
|
85.46 score on a scale
Standard Deviation 16.79
|
|
The Western Ontario and McMaster Universities Arthritis Index (WOMAC)
5-year
|
86.13 score on a scale
Standard Deviation 15.49
|
89.14 score on a scale
Standard Deviation 15.11
|
SECONDARY outcome
Timeframe: Preoperatively, 6-week, 6-month and 12 month visits, 2 years and 5 yearsPopulation: Patients did not complete CRF to protocol in some instances, resulting in exclusion/missing data points.
The EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The participant is asked to indicate his/her health state by indicating the most appropriate level for each of the 5 dimensions. Responses may be converted into a single summary index by applying a formula that essentially attaches values (also called weights) to each of the levels in each dimension. The index can be calculated by deducting the appropriate weights from 1= the value for full health. The EQ VAS records the participant's self-rated health on a vertical, visual analogue scale where the endpoints are labelled from 100 ='Best imaginable health state' to 0= 'Worst imaginable health state'.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Health-related Quality of Life (EQ-5D-3L)
Pre-op EQ-5D Index
|
0.51 score on a scale
Standard Deviation 0.17
|
0.48 score on a scale
Standard Deviation 0.21
|
|
Health-related Quality of Life (EQ-5D-3L)
Pre-op EQ-5D VAS
|
71.43 score on a scale
Standard Deviation 18.11
|
75.66 score on a scale
Standard Deviation 14.28
|
|
Health-related Quality of Life (EQ-5D-3L)
6-week EQ-5D Index
|
0.67 score on a scale
Standard Deviation 0.14
|
0.68 score on a scale
Standard Deviation 0.18
|
|
Health-related Quality of Life (EQ-5D-3L)
6-week EQ-5D VAS
|
79.38 score on a scale
Standard Deviation 13.58
|
80.28 score on a scale
Standard Deviation 19.41
|
|
Health-related Quality of Life (EQ-5D-3L)
6-month EQ-5D Index
|
0.82 score on a scale
Standard Deviation 0.18
|
0.78 score on a scale
Standard Deviation 0.2
|
|
Health-related Quality of Life (EQ-5D-3L)
6-month EQ-5D VAS
|
86.00 score on a scale
Standard Deviation 13.86
|
84.04 score on a scale
Standard Deviation 14.52
|
|
Health-related Quality of Life (EQ-5D-3L)
1-year EQ-5D Index
|
0.89 score on a scale
Standard Deviation 0.16
|
0.84 score on a scale
Standard Deviation 0.20
|
|
Health-related Quality of Life (EQ-5D-3L)
1-year EQ-5D VAS
|
85.48 score on a scale
Standard Deviation 12.46
|
85.91 score on a scale
Standard Deviation 12.22
|
|
Health-related Quality of Life (EQ-5D-3L)
2-year EQ-5D Index
|
0.77 score on a scale
Standard Deviation 0.30
|
0.70 score on a scale
Standard Deviation 0.30
|
|
Health-related Quality of Life (EQ-5D-3L)
2-year EQ-5D VAS
|
81.80 score on a scale
Standard Deviation 18.57
|
84.70 score on a scale
Standard Deviation 11.63
|
|
Health-related Quality of Life (EQ-5D-3L)
5-year EQ-5D Index
|
0.82 score on a scale
Standard Deviation 0.20
|
0.86 score on a scale
Standard Deviation 0.18
|
|
Health-related Quality of Life (EQ-5D-3L)
5-year EQ-5D VAS
|
78.21 score on a scale
Standard Deviation 16.51
|
78.58 score on a scale
Standard Deviation 17.02
|
SECONDARY outcome
Timeframe: 6 week, 6 month, 12 month , 2 years and 5 years visitsPopulation: Patients did not complete CRF to protocol in some instances, resulting in exclusion/missing data points.
The Forgotten Joint Score (FJS) is a 12 question form that asks the patient their level of awareness of their artificial joint in 12 scenarios commonly encountered in daily life. Scores can range from 0 to 100 with a higher score indicating a better outcome (high degree of forgetting the joint in everyday life).
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
The Forgotten Joint Score (FJS-12)
6 week
|
58.12 score on a scale
Standard Deviation 25.53
|
57.21 score on a scale
Standard Deviation 29.32
|
|
The Forgotten Joint Score (FJS-12)
6 month
|
60.47 score on a scale
Standard Deviation 29.57
|
59.96 score on a scale
Standard Deviation 28.27
|
|
The Forgotten Joint Score (FJS-12)
12 month
|
62.47 score on a scale
Standard Deviation 28.99
|
62.01 score on a scale
Standard Deviation 24.84
|
|
The Forgotten Joint Score (FJS-12)
2 year
|
69.21 score on a scale
Standard Deviation 25.93
|
66.22 score on a scale
Standard Deviation 25.54
|
|
The Forgotten Joint Score (FJS-12)
5 year
|
68.04 score on a scale
Standard Deviation 28.824
|
74.12 score on a scale
Standard Deviation 23.38
|
SECONDARY outcome
Timeframe: Preoperatively, 6-week, 6-months,12 months, 2 years and 5 years postoperativelyPopulation: Patients did not complete CRF to protocol in some instances, resulting in exclusion/missing data points.
The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a minimum score of 0 to a maximum of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
The International Knee Society Score (IKSS)
2 year Range of Motion
|
119.19 score on a scale
Standard Deviation 11.91
|
117.63 score on a scale
Standard Deviation 15.20
|
|
The International Knee Society Score (IKSS)
2 year IKSS Pain
|
73.67 score on a scale
Standard Deviation 9.92
|
70.10 score on a scale
Standard Deviation 16.32
|
|
The International Knee Society Score (IKSS)
2 year IKSS Function
|
83.06 score on a scale
Standard Deviation 17.94
|
80.52 score on a scale
Standard Deviation 23.00
|
|
The International Knee Society Score (IKSS)
Pre-op IKSS Pain
|
40.20 score on a scale
Standard Deviation 15.87
|
37.33 score on a scale
Standard Deviation 14.82
|
|
The International Knee Society Score (IKSS)
Pre-op IKSS Function
|
54.06 score on a scale
Standard Deviation 15.70
|
55.50 score on a scale
Standard Deviation 14.82
|
|
The International Knee Society Score (IKSS)
Pre-op Range of Motion
|
118.07 score on a scale
Standard Deviation 11.27
|
116.17 score on a scale
Standard Deviation 15.51
|
|
The International Knee Society Score (IKSS)
6 week IKSS Pain
|
63.02 score on a scale
Standard Deviation 15.37
|
58.30 score on a scale
Standard Deviation 18.28
|
|
The International Knee Society Score (IKSS)
6 week IKSS Function
|
63.33 score on a scale
Standard Deviation 16.90
|
64.26 score on a scale
Standard Deviation 22.26
|
|
The International Knee Society Score (IKSS)
6 week Range of Motion
|
108.64 score on a scale
Standard Deviation 17.58
|
107.28 score on a scale
Standard Deviation 14.99
|
|
The International Knee Society Score (IKSS)
6 month IKSS Pain
|
76.32 score on a scale
Standard Deviation 12.72
|
68.77 score on a scale
Standard Deviation 18.81
|
|
The International Knee Society Score (IKSS)
6 month IKSS Function
|
82.17 score on a scale
Standard Deviation 17.72
|
76.85 score on a scale
Standard Deviation 21.30
|
|
The International Knee Society Score (IKSS)
6 month Range of Motion
|
117.24 score on a scale
Standard Deviation 13.31
|
113.09 score on a scale
Standard Deviation 21.31
|
|
The International Knee Society Score (IKSS)
12 month IKSS Pain
|
76.96 score on a scale
Standard Deviation 14.65
|
73.29 score on a scale
Standard Deviation 15.08
|
|
The International Knee Society Score (IKSS)
12 month IKSS Function
|
83.96 score on a scale
Standard Deviation 17.38
|
80.82 score on a scale
Standard Deviation 20.22
|
|
The International Knee Society Score (IKSS)
12 month Range of Motion
|
118.19 score on a scale
Standard Deviation 12.69
|
116.57 score on a scale
Standard Deviation 12.11
|
|
The International Knee Society Score (IKSS)
5 year IKSS Pain
|
73.26 score on a scale
Standard Deviation 12.19
|
74.71 score on a scale
Standard Deviation 8.95
|
|
The International Knee Society Score (IKSS)
5 year IKSS Function
|
80.96 score on a scale
Standard Deviation 18.41
|
85.96 score on a scale
Standard Deviation 16.64
|
|
The International Knee Society Score (IKSS)
5 year Range of Motion
|
122.24 score on a scale
Standard Deviation 6.69
|
120.43 score on a scale
Standard Deviation 9.16
|
SECONDARY outcome
Timeframe: 3 monthsPopulation: Participants=knees
The Perth CT protocol is a comprehensive assessment of total knee replacement (TKR) component position and orientation. The alignment of the TKR components is measured against the mechanical axis and the transepicondylar axis of the lower extremity. The posted data represents the mean angle between the femoral component and mechanical axis of the femur, the angle between tibial component and mechanical axis of the tibia, the tibial component slope relative to the sagittal mechanical axis, and the femoral component rotation relative to surgical epicondylar axis (positive value=external rotation). For all degree values posted a positive (+) value= valgus and a negative (-) value = varus.
Outcome measures
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 Participants
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Perth CT Protocol
Coronal mechanical axis:hip knee ankle angle
|
-0.4 degrees
Standard Deviation 3.5
|
-0.7 degrees
Standard Deviation 2.0
|
|
Perth CT Protocol
Coronal angle fem comp and mech axis femur
|
2.0 degrees
Standard Deviation 2.6
|
0.6 degrees
Standard Deviation 1.6
|
|
Perth CT Protocol
Coronal angle tibial comp and mech axis tibia
|
-2.8 degrees
Standard Deviation 3.1
|
-0.7 degrees
Standard Deviation 1.9
|
|
Perth CT Protocol
Sagital tibial component slope
|
3.6 degrees
Standard Deviation 2.5
|
1.3 degrees
Standard Deviation 2.4
|
|
Perth CT Protocol
Femcomp rotationrelative to surg epicond axis+=ER
|
-0.5 degrees
Standard Deviation 2.5
|
1.5 degrees
Standard Deviation 2.5
|
Adverse Events
OtisMed® ShapeMatch® With Triathlon
Stryker Precision Knee Navigation
Serious adverse events
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 participants at risk
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 participants at risk
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Cardiac disorders
Non-operative site
|
10.2%
5/49 • Number of events 6 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
8.0%
4/50 • Number of events 5 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Gastrointestinal disorders
Non-operative site
|
8.2%
4/49 • Number of events 5 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
20.0%
10/50 • Number of events 11 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
General disorders
Non-operative site
|
6.1%
3/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
6.0%
3/50 • Number of events 6 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Hepatobiliary disorders
Non-operative site
|
6.1%
3/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Infections and infestations
Operative site
|
2.0%
1/49 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
6.0%
3/50 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Musculoskeletal and connective tissue disorders
Non-operative site
|
42.9%
21/49 • Number of events 26 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
42.0%
21/50 • Number of events 33 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Musculoskeletal and connective tissue disorders
Operative site
|
4.1%
2/49 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Non-operative site
|
6.1%
3/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
8.0%
4/50 • Number of events 4 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Psychiatric disorders
Non-operative site
|
4.1%
2/49 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Renal and urinary disorders
Non-operative site
|
4.1%
2/49 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
6.0%
3/50 • Number of events 4 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Respiratory, thoracic and mediastinal disorders
Non-operative site
|
8.2%
4/49 • Number of events 8 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
16.0%
8/50 • Number of events 8 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Skin and subcutaneous tissue disorders
Non-operative site
|
4.1%
2/49 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Vascular disorders
Non-operative site
|
8.2%
4/49 • Number of events 5 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
6.0%
3/50 • Number of events 4 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Injury, poisoning and procedural complications
Non-operative site
|
4.1%
2/49 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Reproductive system and breast disorders
Non-operative site
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
2.0%
1/50 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Blood and lymphatic system disorders
Non-operative site
|
2.0%
1/49 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
2.0%
1/50 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Congenital, familial and genetic disorders
Non-operative site
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Ear and labyrinth disorders
Non-operative site
|
2.0%
1/49 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Endocrine disorders
Non-operative site
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Eye disorders
Non-operative site
|
8.2%
4/49 • Number of events 5 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
8.0%
4/50 • Number of events 4 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Immune system disorders
Non-operative site
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Infections and infestations
Non-operative site
|
10.2%
5/49 • Number of events 5 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
18.0%
9/50 • Number of events 13 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Investigations
Operative site
|
2.0%
1/49 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
2.0%
1/50 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Metabolism and nutrition disorders
Non-operative site
|
2.0%
1/49 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Nervous system disorders
Non-operative side
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Pregnancy, puerperium and perinatal conditions
Non-operative side
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Product Issues
Non-operative side
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Social circumstances
Non-operative site
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Surgical and medical procedures
Operative site
|
6.1%
3/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
8.0%
4/50 • Number of events 7 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Surgical and medical procedures
Non-operative site
|
51.0%
25/49 • Number of events 35 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
56.0%
28/50 • Number of events 42 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
Other adverse events
| Measure |
OtisMed® ShapeMatch® With Triathlon
n=49 participants at risk
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System and OtisMed® ShapeMatch® Technology.
|
Stryker Precision Knee Navigation
n=50 participants at risk
Participants who underwent Total Knee Replacement (TKR) with the Stryker Triathlon® Total Knee System guided by Stryker Precision Knee Navigation.
|
|---|---|---|
|
Injury, poisoning and procedural complications
Operative site
|
12.2%
6/49 • Number of events 6 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Eye disorders
Non-operative site
|
6.1%
3/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Gastrointestinal disorders
Non-operative site
|
12.2%
6/49 • Number of events 7 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
General disorders
Non-operative site
|
0.00%
0/49 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
6.0%
3/50 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Infections and infestations
Non-operative site
|
4.1%
2/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
10.0%
5/50 • Number of events 6 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Injury, poisoning and procedural complications
Non-operative site
|
6.1%
3/49 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
4.0%
2/50 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Musculoskeletal and connective tissue disorders
Operative site
|
4.1%
2/49 • Number of events 2 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
8.0%
4/50 • Number of events 4 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Musculoskeletal and connective tissue disorders
Non-operative site
|
16.3%
8/49 • Number of events 12 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
20.0%
10/50 • Number of events 14 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Product Issues
Operative site
|
12.2%
6/49 • Number of events 6 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
0.00%
0/50 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Respiratory, thoracic and mediastinal disorders
Non-operative site
|
2.0%
1/49 • Number of events 1 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
6.0%
3/50 • Number of events 3 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
|
Surgical and medical procedures
Non-operative site
|
14.3%
7/49 • Number of events 9 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
12.0%
6/50 • Number of events 7 • 5-years
Elective procedures not included.e.g.non-study joint replacement/revision, rotator cuff repair,carpal tunnel release,cataract,intra-ocular \& bunion procedures,total shoulder repair,laminectomy,microdiscectomy,breast reduction,cervical spine fusion,\& mid/flat-foot surgery.Industry standard AE terms not used;specific AE terms not used for all AEs.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Discloser must give at least 40 days notice to Sponsor including a copy of the proposed publication. The Sponsor can then provide comments (which Discloser is not bound to follow), request delay of publication by no more than 120 days to allow for Sponsor to protect its intellectual property, or request that the Discloser remove certain proprietary or confidential information from the study (other than the results of the study).
- Publication restrictions are in place
Restriction type: OTHER